AI
VRTX icon

Atomic Invest’s Vertex Pharmaceuticals VRTX Stock Holding History

Atomic Invest’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.34K Sell
11
-7
-39% -$3.1K ﹤0.01% 317
2026
Q1 		$7.9K Buy
18
+3
+20% +$1.4K ﹤0.01% 274
2025
Q4 		$6.73K Buy
+15
New +$6.46K ﹤0.01% 239

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Atomic Invest's VRTX Position: Q2 2026 in Review

Atomic Invest reduced its Vertex Pharmaceuticals (VRTX) stake by 39% in Q2 2026, selling an estimated $3.1K and leaving 11 shares worth $5.34K. The position accounts for ﹤0.01% of the portfolio, ranked #317.

Atomic Invest first reported a position in VRTX in Q4 2025 and has held it in 3 quarters since. The position peaked at $7.9K in Q1 2026. 1,763 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Atomic Invest held 11 shares of Vertex Pharmaceuticals worth $5.34K as of Q2 2026.
  • Atomic Invest sold 7 Vertex Pharmaceuticals shares in Q2 2026, an estimated $3.1K.
  • Vertex Pharmaceuticals made up ﹤0.01% of Atomic Invest's portfolio in Q2 2026, its #317 holding.
  • Atomic Invest first reported a position in Vertex Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Atomic Invest's Vertex Pharmaceuticals position peaked at $7.9K in Q1 2026.
  • 1,763 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Atomic Invest's 13F filing for Q2 2026, filed 25 Sep 2026.